De-implementing inappropriate inhaled steroids use in Dutch COPD patients in primary care
C. de Jong (Groningen, Netherlands), J. Van Boven (Groningen, Netherlands), T. Schermer (Nijmegen, Netherlands), R. Riemersma (Groningen, Netherlands), E. Brill (Groningen, Netherlands), M. Van Den Berge (Groningen, Netherlands), T. Van Der Molen (Groningen, Netherlands), J. Kocks (Groningen, Netherlands)
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. de Jong (Groningen, Netherlands), J. Van Boven (Groningen, Netherlands), T. Schermer (Nijmegen, Netherlands), R. Riemersma (Groningen, Netherlands), E. Brill (Groningen, Netherlands), M. Van Den Berge (Groningen, Netherlands), T. Van Der Molen (Groningen, Netherlands), J. Kocks (Groningen, Netherlands). De-implementing inappropriate inhaled steroids use in Dutch COPD patients in primary care. 5008
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
COPD guides and inhaled corticosteroids. Is there an adequate use in primary care? Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care Year: 2016
Inappropriate overuse of inhaled corticosteroids in patients with moderate COPD in UK primary care Source: Annual Congress 2011 - Disease management in specific primary care populations Year: 2011
Characteristics of COPD patients treated with inhaled corticosteroid in primary care Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018
Predictors of inhaled corticosteroid therapy in COPD alone compared to COPD with concomitant asthma managed in primary care Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019
Prescribing patterns of inhaled corticosteroids in asthma amongst primary care physicians in Singapore Source: Virtual Congress 2021 – Primary care organisation and epidemiology Year: 2021
Inhaled steroids prescribing in patients with COPD in the community Source: Eur Respir J 2001; 18: Suppl. 33, 59s Year: 2001
Concomitant use of long-acting beta-agonists with inhaled corticosteroids among asthma patients in the UK primary care Source: Annual Congress 2007 - Miscellaneous epidemiological aspects of respiratory disease Year: 2007
SABA and ICS use among mild asthma patients in UK primary care Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies Year: 2019
Characteristics of COPD patients prescribed ICS managed in general practice vs. secondary care Source: Virtual Congress 2021 – Therapies for respiratory diseases in primary care and COVID - 19 Year: 2021
Discontinuation of inhaled corticosteroid treatment in patients with COPD diagnosed in general practice Source: Eur Respir J 2002; 20: Suppl. 38, 212s Year: 2002
Inhaled corticosteroids are over prescribed in patients with COPD, attending hospital Source: Eur Respir J 2006; 28: Suppl. 50, 429s Year: 2006
Characteristics of patients receiving inhaled treatment in primary care Source: Annual Congress 2009 - Respiratory physiology Year: 2009
Reducing inappropriate high dose ICS prescribing for COPD in primary care using respiratory integrated care virtual clinics Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care Year: 2015
Stepping-down inhaled corticosteroid therapy in stable asthma: a secondary care perspective Source: Eur Respir J 2005; 26: Suppl. 49, 277s Year: 2005
Reducing the use of inhaled corticosteroids in mild COPD patients treated in primary care by a training program in national guidelines and using a portable device to measure pulmonary function Source: Eur Respir J 2005; 26: Suppl. 49, 294s Year: 2005
Asthma-related resource use and costs for patients prescribed inhaled corticosteroids compared to leukotriene modifiers in clinical practice Source: Annual Congress 2010 - Management of airway disease Year: 2010
Reasons for inhaled corticosteroid non-adherence disclosed by African American adults during primary care visits for uncontrolled asthma Source: Virtual Congress 2020 – Novel insights into nursing interventions for managing patients with asthma and COPD Year: 2020
Lung function, symptoms and prescription of inhaled steroids and long acting β2 agonists in patients managed by an integrated COPD team Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016
Inhaled corticosteroid withdrawal may improve outcomes in elderly patients with COPD exacerbation: a nationwide database study Source: ERJ Open Res, 6 (1) 00246-2019; 10.1183/23120541.00246-2019 Year: 2020
Asthma control among patients receiving inhaled corticosteroids in general practice in Thailand Source: Annual Congress 2010 - Questionnaires use and psychological aspects in asthma Year: 2010